When

Register today to attend IOA's 2020 Fall Seminar, to be held on Saturday, October 17, 2020, at the Embassy Suites Hotel & Conference Center in Noblesville, Indiana! This optometric continuing education (CE) event offers eight (8) hours of Legend Drug/IOB continuing education credit.

Coronavirus COVID-19 Precautions:
Committed to the health and safety of our attendees, IOA and Embassy Suites will be in complete compliance with CDC and Indiana government guidelines in effect at the time of the seminar.

Precautions for this event will include:

Requiring attendees to wear masks
Enforcing social distancing requirements (seating will be set accordingly)
COVID-compliant on-site registration and CE documentation procedures
Additional disinfection/sanitation
A separate entrance to the conference area from the parking lot

Health checks may be conducted as attendees arrive at the entrance to the building.

7:30 am – 9:00 am Continental Breakfast

8:00 am – 9:00 am Optional Bonus Hour of CE
What’s New in Ocular Surface Disease
Paul Karpecki, OD, FAAO, Lexington, KY
This lecture allows the participant an understanding of the predisposing factors, diagnosis, and treatment options for ocular surface diseases and, in particular, dry eye disease, blepharitis, MGD and allergic conjunctivitis. Dry eye disease is the most common medical condition optometry faces so it is important to stay informed of the latest diagnostic tests and treatment options to successfully manage these patients. - Trt/Mngmnt Anterior Segment 1 hour IOB and Legend Drug
Sponsored by Bausch & Lomb

9:00 am – 11:00 am
Innovations in Eyecare
Paul Karpecki, OD, FAAO, Lexington, KY
This course is a fast-paced peak into exciting diagnostic and treatment technologies that currently or soon will affect optometry and our patients. Technologies range from stem cell innovations to point of care diagnostics, advanced surgical procedures, new diagnostic devices, and exciting topical therapies for ocular diseases that once had no treatment. - Trt/Mngmnt Anterior Segment 2 hours IOB and Legend Drug
Sponsored by Bausch & Lomb

11:00 am – 12:00 pm
The Impact of Macular Nutrition on Risk of Progression and Visual Performance in AMD
Mark Roark, OD, FAAO, Fishers, IN
This course will provide a thorough understanding of the structure and function of the macula and the role of macular carotenoids in reducing the risk of AMD progression and improving visual performance. A summary of key observational and randomized controlled trials that must inform our nutritional recommendations for patients with AMD and for those at risk will be given. Discussion will also include best practices and controversies surrounding the use of zinc, beta carotene and omega-3s inpatients with AMD. Identifying patients most likely to benefit from nutritional intervention will be addressed. - Trt/Mngmnt Posterior Segment 1 hour IOB and Legend Drug
Sponsored by MacuHealth

12:00 pm – 1:00 pm Lunch (included in registration fee)

1:00 pm – 3:00 pm
Glaucoma Suspect - When to Diagnose and When to Treat
Austin Lifferth, OD, FAAO, Warsaw, IN
Michael Cymbor, OD, FAAO, State College, PA
Why do some patients continue to be diagnosed with moderate advanced glaucoma? Are there clues to detecting those who are at the highest risk for developing glaucoma? Glaucoma suspect patients represent that diagnostic grey zone between normal patients and early glaucoma...and they should individually be considered guilty until proven innocent. This interactive, clinical course reviews evidence-based clues for earlier detection and more timely diagnosis. - Glaucoma 2 hours IOB and Legend Drug

3:00 pm – 5:00 pm
Progressing Glaucoma - When to Manage with Meds, Laser, and Surgery
Austin Lifferth, OD, FAAO, Warsaw, IN
Michael Cymbor, OD, FAAO, State College, PA
Most eye doctors are comfortable with starting a glaucoma patient on a prostaglandin analogue. It may be more difficult to decide the next treatment when a patient progresses on a prostaglandin. This talk will discuss the topical, laser and surgical options available when a practitioner encounters this common crossroad. This talk will address exfoliation and pigmentary glaucoma, as well as narrow angles and normal tension glaucoma. - Glaucoma 2 hours IOB and Legend Drug

All courses are eligible for IOB/legend drug continuing education credit.

Schedule subject to change. Should any scheduling changes be necessary, they will be posted at www.ioa.org.

Questions? Contact Bridget Sims at (317) 237-3560 or at blsims@ioa.org.

Going Green? Please remember your choice if you choose to go green and not have a seminar booklet printed for you. As a COVID-safety measure, all registration materials will be pre-set at the tables in the lecture hall. Participants who choose to go green will find a green sheet of paper instead of a booklet at your seat.

REFUND POLICY: All requests for refunds must be made in writing and must be postmarked or sent via email no later than October 7, 2020. Refund requests made on or before October 7, 2020, will receive a full refund. Requests made between October 7 and October 16, 2020, will receive a 75% refund. Except for individuals who report COVID-like symptoms, no refunds will be made after October 16, 2020. Individuals who experience COVID-like symptoms between October 7 and the day of the event are asked to not attend and will receive a full refund.

IOA's NEW ADDRESS:

Indiana OPTOMETRY | Indiana Optometric Association, Inc.
275 N. Medical Drive | # 3363
Carmel, IN 46082
(317) 237-3560 | (317) 237-3564 FAX

When

Where

CONTACT

INDIANA's ON-LINE & SELF-STUDY CE RULES

IOA's 2020 CORPORATE SPONSORS

Indiana OPTOMETRY's

2020 Fall Seminar

October 17, 2020Eight Hours of Legend Drug/IOB Continuing Education

October 17, 2020
Eight Hours of Legend Drug/IOB Continuing Education